The research on BPC-157 paints an interesting picture of what future peptides for injury recovery might look like
The efficiency between oral versus injectable forms can differ considerably due to varying absorption rates and utilization by the body
believes it is important that all Glastonbury patients understand that while the results are very promising, BPC-157 Peptide Therapy is cutting-edge and is not yet considered a mainstream treatment
INTERESTED IN BPC-157
Documented side effects are usually mild to moderate: Injection-site pain, redness, or bruising Flushing Increased heart rate Nausea or gastrointestinal upset Headache Urinary changes or a fishy body odor at higher choline doses Because these are compounded products, sterile technique, pharmacy sourcing, and formulation verification matter
Not intended for human or animal consumption, diagnostic use, therapeutic use, clinical use, food use, cosmetic use, or household use